Discovery of a novel FAK inhibitor, NVP-TAE226, and its activities on in vivo and in vitro models

被引：1
|
作者：
Kawahara, E.
Yamaura, T.
Ohmori, O.
Nonomura, K.
Murakami, Y.
Niwa, S.
Meyer, T.
Mestan, J.
Honda, T.
Hatakeyama, S.
机构：
[1] Novartis Inst Biomed Res, Grobal Discovery Chem, Tsukuba, Ibaraki, Japan
[2] Novartis Inst Biomed Res, Discovery Biol, Tsukuba, Ibaraki, Japan
[3] Novartis Inst Biomed Res, Autoimmunity & Transplant, Vienna, Austria
[4] Novartis Inst Biomed Res, Expert Platform Kinase, Basel, Switzerland
来源：
EJC SUPPLEMENTS | 2006年 / 4卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(06)70566-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
561
引用
收藏
页码：170 / 170
页数：1
相关论文
共 50 条
  • [1] NVP-TAE226, an inhibitor of FAK, induces regression of solid tumor
    Hatakeyama, S.
    Tomioka, D.
    Ohmori, O.
    Matsuura, N.
    Masuya, K.
    Miyake, T.
    Umemura, I.
    Kanazawa, T.
    Honda, T.
    Kawahara, E.
    [J]. EJC SUPPLEMENTS, 2006, 4 (12): : 175 - 175
  • [2] Discovery of the Novel mTOR Inhibitor and Its Antitumor Activities In Vitro and In Vivo
    Xie, Hua
    Lee, Mee-Hyun
    Zhu, Feng
    Reddy, Kanamata
    Huang, Zunnan
    Kim, Dong Joon
    Li, Yan
    Peng, Cong
    Lim, Do Young
    Kang, Soouk
    Jung, Sung Keun
    Li, Xiang
    Li, Haitao
    Ma, Weiya
    Lubet, Ronald A.
    Ding, Jian
    Bode, Ann M.
    Dong, Zigang
    [J]. MOLECULAR CANCER THERAPEUTICS, 2013, 12 (06) : 950 - 958
  • [3] The focal adhesion vinase (FAK) inhibitor TAE226 exhibits in vitro and in vivo activity against multiple myeloma.
    Sharkey, Janelle
    Yeh, Sung Lin
    Spencer, Andrew
    [J]. BLOOD, 2006, 108 (11) : 253A - 253A
  • [4] Pharmacological profiling of a dual FAK/IGF-1R kinase inhibitor TAE226 in cellular and in vivo tumor models
    Fukami, Shigemi
    Tomioka, Daisaku
    Murakami, Yutaka
    Honda, Toshiyuki
    Hatakeyama, Shinji
    [J]. BMC RESEARCH NOTES, 2019, 12 (1)
  • [5] Pharmacological profiling of a dual FAK/IGF-1R kinase inhibitor TAE226 in cellular and in vivo tumor models
    Shigemi Fukami
    Daisaku Tomioka
    Yutaka Murakami
    Toshiyuki Honda
    Shinji Hatakeyama
    [J]. BMC Research Notes, 12
  • [6] Focal adhesion kinase inhibition in ovarian carcinoma: In vitro and in vivo characterization of a novel small molecule inhibitor, TAE226
    Lin, Y. G.
    Halder, J.
    Merritt, W. M.
    Spannuth, W. A.
    Nick, A. M.
    Honda, T.
    Kamat, A. A.
    Han, L. Y.
    Kim, T.
    Sood, A. K.
    [J]. GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S84 - S85
  • [7] Discovery of NVP-LAQ824, a novel histone deacetylase inhibitor with in vitro and in vivo antitumor activity.
    Remiszewski, SW
    Sambucetti, LC
    Atadja, P
    Bair, KW
    Bontempo, J
    Cesarz, D
    Chandramouli, N
    Chen, R
    Dean, K
    Diamantidis, G
    Green, MA
    Howell, KL
    Kashi, R
    Kwon, P
    Lassota, P
    Mou, Y
    Nemzek, R
    Perez, LB
    Sorensen, E
    Taplin, F
    Trogani, N
    Versace, R
    Walker, H
    Weltchek-Engler, S
    Wood, AW
    Wu, A
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U46 - U46
  • [8] Anti-tumor effect of a novel FAK inhibitor TAE226 against human oral squamous cell carcinoma
    Kurio, Naito
    Shimo, Tsuyoshi
    Fukazawa, Takuya
    Okui, Tatsuo
    Hassan, Nur Mohammad Monsur
    Honami, Tatsuki
    Horikiri, Yuu
    Hatakeyama, Shinji
    Takaoka, Munenori
    Naomoto, Yoshio
    Sasaki, Akira
    [J]. ORAL ONCOLOGY, 2012, 48 (11) : 1159 - 1170
  • [9] In vitro and in vivo activities of Syn2190, a novel β-lactamase inhibitor
    Nishida, K
    Kunugita, C
    Uji, T
    Higashitani, F
    Hyodo, A
    Unemi, N
    Maiti, SN
    Phillips, OA
    Spevak, P
    Atchison, KP
    Salama, SM
    Atwal, H
    Micetich, RG
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (08) : 1895 - 1900
  • [10] Anti-tumor effect in human breast cancer by TAE226, a dual inhibitor for FAX and IGF-IR in vitro and in vivo
    Kurio, Naito
    Shimo, Tsuyoshi
    Fukazawa, Takuya
    Takaoka, Munenori
    Okui, Tatsuo
    Hassan, Nur Mohammad Monsur
    Honami, Tatsuki
    Hatakeyama, Shinji
    Ikeda, Masahiko
    Naomoto, Yoshio
    Sasaki, Akira
    [J]. EXPERIMENTAL CELL RESEARCH, 2011, 317 (08) : 1134 - 1146
12345